共 168 条
- [1] Ramirez RJ(2017)Tranexamic acid update in trauma Crit Care Clin 33 85-99
- [2] Spinella PC(2012)Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial BMC Emerg Med 12 3-316
- [3] Bochicchio GV(2017)Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis Wien Klin Wochenschr 129 303-17
- [4] Ker K(2021)Tranexamic acid and trauma coagulopathy: where are we now? Br J Anaesth 126 12-870
- [5] Kiriya J(2019)The why and how our trauma patients die: a prospective Multicenter Western Trauma Association study J Trauma Acute Care Surg 86 864-79
- [6] Perel P(2009)Intracranial bleeding in patients with traumatic brain injury: a prognostic study BMC Emerg Med 9 15-617
- [7] Edwards P(2013)The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients Health Technol Assess 17 1-11031
- [8] Shakur H(2012)Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis Drugs 72 585-S199
- [9] Roberts I(2019)Efficacy and safety of tranexamic acid in orthopaedic trauma surgery: a meta-analysis Eur Rev Med Pharmacol Sci 23 11025-87
- [10] Pabinger I(2015)Tranexamic acid in trauma: how should we use it? J Thromb Haemost 13 S195-1584